LILIA HENRIQUEZ: Open Payments
NPI 1184276735 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 9 payments from 6 companies in 2025. Trend: 2023 $224 · 2024 $141 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $253 |
| Neurocrine BioSciences, Inc. | 2 | $149 |
| Luye Pharma (USA) Ltd. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $123 |
| Alkermes, Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
Products named: INGREZZA, ERZOFRI EXTENDED-RELEASE, REXULTI, COBENFY, LYBALVI, ABILIFY MAINTENA, UZEDY, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
